Home » Kjersti Anderson

Kjersti Anderson

Senior Analyst

Kjersti Anderson is a Senior Analyst at CBPartners.

Connect with Kjersti Anderson



Published Articles

Misconceptions of the 340B Drug Discount Program

Since its inception over 30 years ago, the 340B drug pricing program policy has evolved allowing for unprecedented expansion and influence. With this it has also become highly contested, especially in recent years as more legislation has been put forward to close 340B loopholes.

10 Myths About the 340B Drug Pricing Program That You Should Know About